With Bashar al-Assad's regime in Syria now in decline, the future of his vast drug empire, particularly the Captagon trade, remains uncertain. For years, Syria has been the global hub for Captagon production, generating billions in revenue for Assad's family, the Syrian military, Iran, and Hezbollah.